HealthDay News — For patients with type 2 diabetes and hemoglobin A1c (HbA1c) >8% following multiple daily injections (MDI), continuous subcutaneous insulin infusion (CSII) is associated with a ...

From developing a subcutaneous implant containing insulin-secreting cells or a hydrogel infused with slow-release glucagon-like peptide (GLP-1), researchers have long focused on reducing the ...

The subcutaneous route allows drugs such as insulin and heparin to be absorbed slowly over a period of time. Using the correct injection technique and selecting the correct site will minimise the risk ...

Injection of “smart insulin” regulates blood glucose levels for one week Tests in animals show the material works like the body's own system. Ivan Paul – Dec 27, 2023 6:57 AM | 81 ...

All participants were aged at least 60 years and had type 1 diabetes, including 1,404 who used subcutaneous insulin infusion (median age, 66.4 years; 52% women) and 8,143 who used insulin ...

July 2, 2004 — Continuous subcutaneous insulin infusion (CSII) improved glycemic control in children and adolescents with type 1 diabetes better than did multiple daily injection (MDI) with ...

I have heard that we can give subcutaneous (SC) regular insulin every one to two hours instead of giving an IV infusion. Is that true?—Dennis A. Fito, MD, ...

Abstract The subcutaneous route allows drugs such as insulin and heparin to be absorbed slowly over a period of time. Using the correct injection technique and selecting the correct site will minimise ...